IKENA ONCOLOGY
Live / Registered — Registered (as of 18 Jul 2023)
What this means for you
Registered since 18 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88585274
- Registration number
- 7115604
- Mark type
- Stylized text
- Filed
- 20 Aug 2019
- Published for opposition
- 31 Mar 2020
- Registered
- 18 Jul 2023
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; Clinical research in the field of cancer therapeutics and pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- IKENA ONCOLOGY, INC., Boston, MA, US
- IKENA ONCOLOGY, INC., Boston, MA, US
- Kyn Therapeutics Inc., Boston, MA, US
- Kyn Therapeutics Inc., Boston, MA, US
Prosecution history
- 18 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 15 Jun 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Jun 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 May 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 22 May 2023 — USE AMENDMENT FILED
- 22 May 2023 — TEAS STATEMENT OF USE RECEIVED
- 03 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2022 — SOU EXTENSION 5 GRANTED
- 22 Nov 2022 — SOU EXTENSION 5 FILED
- 02 Dec 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 25 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 May 2022 — SOU EXTENSION 4 GRANTED
- 23 May 2022 — SOU EXTENSION 4 FILED